Rating total cerebral small-vessel disease Does it add up?

Neurology

Volumn 83, Issue 14, 2014, Pages 1224-1225

  Jickling, Glen C ^a   Chen, Christopher ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; LOSARTAN;

BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CADASIL; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DISEASE SEVERITY; EDITORIAL; GAIT DISORDER; HUMAN; LACUNAR STROKE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; BRAIN; CEREBROVASCULAR ACCIDENT; FEMALE; MALE; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

BRAIN; BRAIN ISCHEMIA; CEREBRAL SMALL VESSEL DISEASES; FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; STROKE; STROKE, LACUNAR;

EID: 84921779386     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000843     Document Type: Editorial

References (10)

1. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701.
2. Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 2014; 83: 1228-1234.
3. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. Lancet Neurol 2009; 8: 643-653.
4. Lanfranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: A systematic review. Stroke 2010; 41: E513-e518.
5. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838.
6. Gao FQ, Swartz RH, Scheltens P, et al. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study. J Alzheimers Dis 2011; 26(suppl 3): 379-388.
7. van der Lijn F, Verhaaren BF, Ikram MA, et al. Automated measurement of local white matter lesion volume. Neuroimage 2012; 59: 3901-3908.
8. Jickling GC, Stamova B, Ander BP, et al. Profiles of lacunar and nonlacunar stroke. Ann Neurol 2011; 70: 477-485.
9. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: Greater precision but with greater uncertainty? JAMA 2003; 289: 2554-2559.
10. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): A randomised trial against atenolol. Lancet 2002; 359: 995-1003.